Position in GERN
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$833,381
+$56,437 QoQ
Shares Held
651,079
+24.9% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 258 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. GERN ranks #67 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
315,335 | $17,680,833 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
62,523 | $8,298,677 | |
| 3 | CGON |
CG Oncology, Inc.
|
89,218 | $6,338,938 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
97,610 | $5,891,739 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
61,014 | $5,806,702 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
55,281 | $5,388,791 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
93,981 | $5,339,060 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
110,388 | $5,192,651 |
All Filings in GERN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $833,381 | 651,079 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $776,944 | 521,439 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $691,889 | 524,159 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $414,437 | 302,509 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $484,419 | 343,560 | Shares | Defined | 2025-08-11 | |
| 2024-09-30 | $2,068,669 | 455,654 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,961,725 | 462,671 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,271,008 | 385,154 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $757,030 | 358,782 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $818,956 | 386,300 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,200,446 | 373,971 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $624,923 | 287,983 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $625,403 | 258,431 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $452,478 | 332,705 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $454,567 | 372,596 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $538,336 | 392,946 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $591,648 | 419,609 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $887,512 | 561,717 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $892,263 | 561,172 | Shares | Defined | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||